The crypto market experiences a slight rebound, but funding rates indicate that BTC and ETH remain in a bearish range.
BlockBeats News, July 26 — According to data from an exchange, Bitcoin is currently trading at $64,314.13, up 0.44% in the past 24 hours; Ethereum is trading at $1,878.63, up 1.16% in the past 24 hours. Despite the slight rebound in the crypto market, sentiment in the perpetual contracts market remains weak.
Latest data from CoinGlass shows that BTC's open interest and trading volume weighted funding rates are 0.0043% and 0.0029% respectively, but funding rates on some trading platforms have returned to neutral; ETH's rates are 0.0028% and 0.0018% respectively, both below the bearish threshold of 0.005%, indicating stronger bearish sentiment for ETH compared to BTC.
BlockBeats note: Funding rates are the rate set by cryptocurrency trading platforms to keep the price of perpetual contracts in line with the underlying asset’s price, serving as a mechanism for capital exchange between long and short traders. Trading platforms do not charge this fee. A funding rate of 0.01% represents the benchmark rate; above 0.01% signals bullish market sentiment, while below 0.005% indicates bearish market sentiment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SemiAnalysis: Nvidia (NVDA.US) Vera Rubin’s revenue per gigawatt is 39% higher and profit is 42% higher compared to GB300
According to estimates from SemiAnalysis, Rubin NVL72 generates 39% higher annual revenue per gigawatt compared to the strongest GB300 configuration, with profits 42% higher.

Guoyuan International: Maintains Buy Rating on Shuidi (WDH.US), AI-Driven Rapid Performance Growth
After Waterdrop (WDH.US) released its Q2 2026 results, Guoyuan International issued a research report maintaining a "Buy" rating on Waterdrop with a target price of $1.25.

Market Chatter: Walmart, Scan Health Plan Collaborate on Medicare Advantage Plan
TD Cowen Initiates Arcus Biosciences at Buy
